Amwell Q2 Revenue Drops 27% but Cost Cuts Narrow Loss, Full-Year Outlook Raised

summarizeSummary

Amwell reported Q2 2026 revenue of $52 million, down 27% year-over-year, but narrowed its net loss to $9.6 million through cost cuts. The company raised its full-year revenue and Adjusted EBITDA guidance and reiterated its goal of positive operating cash flow by Q4 2026.

check_boxKey Events · Earnings and Guidance · AMWL

• Q2 Revenue Decline

  Revenue fell 27% year-over-year to $52.0 million, at the top end of guidance, driven by lower AMG visit revenue and subscription growth.

• Loss Narrows on Cost Cuts

  Net loss improved to $9.6 million from $10.3 million in Q1 2026, as operating expenses dropped sharply across R&D, sales, and G&A.

• Full-Year Guidance Raised

  Revenue outlook raised to $200-$205 million (from $195-$205 million) and Adjusted EBITDA improved to ($9)-($7) million (from ($16)-($12) million).

• Positive Cash Flow Target

  Company reiterated objective to achieve positive cash flow from operations in Q4 2026, supported by $195.9 million in cash reserves.

auto_awesomeAnalysis · AMWL · Trade & Services

Amwell's Q2 revenue dropped 27% year-over-year to $52 million, but aggressive cost-cutting narrowed the net loss to $9.6 million and turned operating cash flow positive. The company raised the low end of its full-year revenue guidance and significantly improved its Adjusted EBITDA outlook, projecting positive cash flow from operations by Q4 2026. The DHA's intent to make Amwell a prime contractor adds a potential growth catalyst. While the top-line decline is concerning, the improved profitability trajectory and cash position extending the runway are positive signals for a company that recently replaced its auditor and saw a co-founder resign.